GlassScriptPhysician profile
Tony Shen
NPI 1104367374
$17,595.08
in general payments reported to CMS, 2019-2025
6 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,343 · 2023: $8,972 · 2024: $2,140 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,542 · Consulting Fee: $1,750 · Food and Beverage: $1,703 · Travel and Lodging: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,541.54 |
| Consulting Fee | $1,750.00 |
| Food and Beverage | $1,703.35 |
| Travel and Lodging | $1,257.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,150.21 | 2022-2023 | Real Intelligence |
| Zimmer Biomet Holdings, INC. | $4,146.74 | 2023-2024 | Rosa, Persona, Avenir |
| Stryker Corporation | $679.93 | 2022-2023 | Mako, Triathlon |
| Uoc USA INC | $321.06 | 2023-2025 | Conformity and Momentum Cup, Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee |
| Depuy Synthes Sales INC. | $156.38 | 2024 | Velys, Reclaim |
| Orthalign INC | $140.76 | 2023 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.